Top View
- Cytarabine Injection for Intravenous, Intrathecal and Subcutaneous Use Only
- Chapter 12: Pharmacokinetics of Chemotherapeutic Agents in Kidney Disease
- Two Distinct Molecular Mechanisms Underlying Cytarabine Resistance in Human Leukemic Cells
- Safe Handling of Hazardous Chemotherapy Drugs in Limited-Resource Settings
- New Zealand Data Sheet 1. Product Name Cytarabine 2
- Response and Toxicity to Cytarabine Therapy in Leukemia and Lymphoma: from Dose Puzzle to Pharmacogenomic Biomarkers
- Capecitabine-Induced Hand-Foot Syndrome Complicated by Pseudomonal Superinfection Resulting in Bacterial Sepsis and Death Case Report and Review of the Literature
- Initial Protocol
- DRUG NAME: Gemcitabine
- Cytarabine Injection
- DA (3+8)–Cytarabine-Daunorubicin In-Patient Regimen
- Randomized Trial of Vitamin B6 for Preventing Hand-Foot Syndrome
- Toxicity and Anti-Tumor Effects of Cytarabine and Doxorubicin on Acute Myeloid Leukemia
- Hand Foot Syndrome Associated with Standard Dose Cytarabine
- Data Sheet 1 Product Name
- Combination Effect of Antitumor Agents, Including Doxorubicin
- Randomized Trial of Intermediate-Dose Cytarabine In
- Schedule-Dependent Synergism and Antagonism Between Methotrexate
- Genomic Variants of Cytarabine Sensitivity Associated with Treatment Related Mortality In
- Primary CNS Lymphoma)
- Omacetaxine Mepesuccinate) for Injection, for Hemorrhage
- Characterization of Cytarabine-Resistant Leukemic Cell Lines Established from Five Different Blood Cell Lineages Using Gene Expression and Proteomic Analyses
- Cytostatics in the Aquatic Environment: Analysis, Occurrence, and Possibilities for Removal
- Genetic Factors Influencing Pyrimidine-Antagonist Chemotherapy
- Nedd8-Activating Enzyme Inhibitor MLN4924 Provides Synergy with Mitomycin C Through Interactions with ATR, BRCA1/BRCA2, and Chromatin Dynamics Pathways
- An Atypical Dorsal Presentation of Paclitaxel-Induced Acral Erythema Erin Lowe, DO,* Miesha Merati, DO,** Jenifer R
- Skin Toxicity Associated with Clofarabine and Cytarabine for the Rt Eatment of Acute Leukemia Bingnan Zhang Yale School of Medicine, [email protected]
- Guideline for Classification of the Acute Emetogenic Potential of Antineoplastic Medication in Pediatric Cancer Patients
- Cancer Drug Costs for a Month of Treatment at Initial Food and Drug
- BC Cancer Protocol Summary for Treatment of Lymphoma Using Intrathecal Methotrexate and Cytarabine
- Prcytarabine Injection
- Nucleoside Analog Cytotoxicity ‐Focus on Enzyme Regulation, Metabolism, and Development of Resistance
- DBL Cytarabine Data Sheet
- Oral Cytarabine Ocfosfate in Acute Myeloid Leukemia and Non-Hodgkin’S Lymphoma – Phase I/II Studies and Pharmacokinetics
- 389.Full-Text.Pdf
- High Dose Methotrexate and Cytarabine
- REVIEW Nucleoside Analogues: Mechanisms of Drug Resistance and Reversal Strategies
- VINCRISTINE (Nordic 2000) Inpatie
- Chemotherapy Protocols and Incidence of Oral Mucositis
- DRUG NAME: Hydroxyurea
- Nucleoside Analogues and Nucleobases in Cancer Treatment
- Palmar-Plantar Erythrodysesthesia (Ppe) Nci Grade and Management | Resources | Contributing Factors | Appendix
- Low-Dose Cytarabine for Acute Myeloid Leukaemia (AML)
- Liposomal Cytarabine As Cancer Therapy: from Chemistry to Medicine
- List Item Withdrawal Assessment Report for Tekinex (PDF/558.5
- Omacetaxine Mepesuccinate
- Cytarabine and Doxorubicin-Induced Palmoplantar Erythrodysesthesia Syndrome: the Possible Role of Voriconazole Interaction
- Hydroxyurea Inclusion.Pdf
- Hazardous Drug List
- Serious Hand-And-Foot Syndrome in Black Patients Treated with Capecitabine: Report of 3 Cases and Review of the Literature
- TABLOID® Brand Thioguanine 40-Mg Scored Tablets